Six years after Covid-19 first shut down the world and spurred unprecedented public health efforts, a new variant of the virus, known as 'Cicada,' is attracting attention. This heavily mutated strain, first identified in South Africa in November 2024, has now been detected in two dozen U.S. states including California, sparking conversations among experts and concerns among the public.

What is the 'Cicada' Variant?

Named after the insect for its metaphorical reemergence, 'Cicada' was initially classified as a variant under monitoring by the World Health Organization (WHO) in December 2024. Recently, however, its spread and unique characteristics have brought it under closer scrutiny. This variant's defining feature lies in its 75 mutations in the spike protein—the portion of the virus responsible for attaching to human cells. Dr. Anne Rimoin, Director of UCLA’s Fielding School of Public Health Center for Global Health Security, explains that while its total case numbers remain low, public health officials are paying attention due to its potential implications.

Why Mutations Matter

Viruses like SARS-CoV-2 mutate as they spread, and while most variations are inconsequential, certain mutations can significantly alter a virus’s behavior. Mutations could make the virus more transmissible, potentially capable of evading some immune defenses, or better equipped to spread in populations with prior immunity. According to Dr. Rimoin, the high mutation count in the Cicada variant warrants monitoring, even if there is no immediate cause for alarm.

“It’s important to understand,” she clarifies, “that just having a large number of mutations doesn’t necessarily make a variant more dangerous. But with public health, we aim to stay ahead of the game.”

Vaccine Effectiveness Against 'Cicada'

One of the most pressing questions is whether current vaccines are effective against Cicada. While there’s evidence that the variant may have some resistance to neutralizing antibodies from both prior infections and vaccinations, experts believe the available vaccines still provide robust protection against severe illness and hospitalization. For now, the advice remains consistent: stay up-to-date on booster shots and maintain preventive measures.

Practical Advice for Prevention

Dr. Rimoin underscored the importance of practicing layered protection, particularly in crowded or poorly ventilated spaces. Simple measures such as wearing a mask when traveling, ensuring adequate ventilation, and maintaining good hygiene can reduce the risk of infection. "It’s not just Covid-19 circulating," she reminded. "There are a lot of other respiratory diseases out there, too.”

Symptoms of 'Cicada'

For those concerned about contracting Cicada, its symptoms align closely with earlier Covid-19 strains: fever, chills, and sore throat. However, because these symptoms overlap with allergies and other circulating illnesses such as the flu, testing remains the most reliable way to determine if someone has contracted Covid-19.

Where Does 'Cicada' Fit in the Current State of Covid-19?

Since the Covid-19 pandemic was declared a worldwide emergency over three years ago, control measures have largely transitioned to an endemic response. Public health systems now focus on managing sporadic variants while preventing healthcare strain. Cicada’s emergence highlights the continued need for monitoring and proactive strategies to address mutations, even as life has largely returned to normalcy for many.

A Measured Approach

While the Cicada variant doesn’t currently pose an immense risk, its existence reminds us of the virus’s potential for change. Monitoring such variants is critical to maintaining control and readiness. Public health officials emphasize that staying informed and adhering to preventive measures where possible are vital for managing future developments.

As of now, Cicada is under observation—one of many variants that have emerged deep into the ongoing story of Covid-19. Whether it will fade into obscurity or rise to prominence remains to be seen.